Glen Research Inks Marketing License Pact with TriLink | GenomeWeb

NEW YORK (GenomeWeb News) – TriLink BioTechnologies said today that it has signed up Glen Research Corporation to sell its CleanAmp PCR solution for use in the production of CleanAmp Primers, under a new license agreement.

By selling the CleanAmp Amidites solution, in which the primer components of the PCR reaction mix, Glen Research's customers will be able to make the CleanAmp Primers in-house, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.